Lombard Medical, Inc. (EVARF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Oct 6, 2025
Lombard Medical Revenue
In the year 2016, Lombard Medical had annual revenue of $12.17M, down -19.49%. Lombard Medical had revenue of $2.40M in the quarter ending December 31, 2016, a decrease of -18.45%.
Revenue
12.17M
Revenue Growth
-19.49%
P/S Ratio
n/a
Revenue / Employee
107.69K
Employees
113
Market Cap
28.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | 12.17M | -2.95M | -19.49% |
| Dec 31, 2015 | 15.11M | 1.84M | 13.84% |
| Dec 31, 2014 | 13.28M | 6.32M | 90.76% |
| Dec 31, 2013 | 6.96M | 785.00K | 12.71% |
| Dec 31, 2012 | 6.18M | -250.00K | -3.89% |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |